MedPath

Sevoflurane

Sevoflurane USP volatile liquid for inhalation

Approved
Approval ID

c808afe1-ebf1-44cf-9187-09656331bff5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 12, 2024

Manufacturers
FDA

Shandong New Time Pharmaceutical Co., Ltd.

DUNS: 545298254

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sevoflurane

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42677-308
Application NumberANDA214382
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sevoflurane
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJanuary 12, 2024
FDA Product Classification

INGREDIENTS (1)

SEVOFLURANEActive
Quantity: 250 mL in 250 mL
Code: 38LVP0K73A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.